The aim of the Needle Exchange Surveillance Initiative (NESI) is to measure and monitor the prevalence of the Hepatitis C virus (HCV) and injecting risk behaviours among people who inject drugs (PWID) in Scotland.
The initiative was initially funded by the Scottish Government as part of the Hepatitis C Action Plan, which stated that efforts to prevent HCV in Scotland must focus on preventing transmission of the virus among PWID. More recently the initiative has been funded under the auspices of the Scottish Government’s Sexual Health and Blood Borne Virus Framework. NESI provides information to evaluate and better target interventions aimed at reducing the spread of infection amongst PWID.
This report presents the results, at the health board level, for the data collection period from July 2017 until October 2018, during which data were collected across the 11 mainland Scottish NHS Boards. These were Ayrshire & Arran , Borders, Dumfries & Galloway, Fife, Forth Valley, Grampian, Greater Glasgow & Clyde, Highland, Lanarkshire, Lothian, and Tayside.
This report also presents the findings of the NESI survey, at Scotland-wide level, from 2008 to 2009 until the most recent survey, 2017 to 2018.